1. Home
  2. AHH vs EYPT Comparison

AHH vs EYPT Comparison

Compare AHH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHH
  • EYPT
  • Stock Information
  • Founded
  • AHH 1979
  • EYPT 1987
  • Country
  • AHH United States
  • EYPT United States
  • Employees
  • AHH N/A
  • EYPT N/A
  • Industry
  • AHH Real Estate
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • AHH Finance
  • EYPT Industrials
  • Exchange
  • AHH Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • AHH 557.9M
  • EYPT 484.4M
  • IPO Year
  • AHH 2013
  • EYPT 2005
  • Fundamental
  • Price
  • AHH $6.92
  • EYPT $8.90
  • Analyst Decision
  • AHH Buy
  • EYPT Strong Buy
  • Analyst Count
  • AHH 3
  • EYPT 8
  • Target Price
  • AHH $9.83
  • EYPT $24.29
  • AVG Volume (30 Days)
  • AHH 797.7K
  • EYPT 918.3K
  • Earning Date
  • AHH 08-06-2025
  • EYPT 08-06-2025
  • Dividend Yield
  • AHH 10.96%
  • EYPT N/A
  • EPS Growth
  • AHH 9.49
  • EYPT N/A
  • EPS
  • AHH 0.10
  • EYPT N/A
  • Revenue
  • AHH $627,963,000.00
  • EYPT $56,042,000.00
  • Revenue This Year
  • AHH N/A
  • EYPT N/A
  • Revenue Next Year
  • AHH $2.11
  • EYPT N/A
  • P/E Ratio
  • AHH $71.41
  • EYPT N/A
  • Revenue Growth
  • AHH N/A
  • EYPT 12.04
  • 52 Week Low
  • AHH $6.10
  • EYPT $3.91
  • 52 Week High
  • AHH $12.46
  • EYPT $13.99
  • Technical
  • Relative Strength Index (RSI)
  • AHH 44.69
  • EYPT 69.94
  • Support Level
  • AHH $6.83
  • EYPT $8.50
  • Resistance Level
  • AHH $7.17
  • EYPT $9.55
  • Average True Range (ATR)
  • AHH 0.14
  • EYPT 0.64
  • MACD
  • AHH -0.01
  • EYPT 0.12
  • Stochastic Oscillator
  • AHH 24.29
  • EYPT 82.29

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: